… of end-organ CMV disease in more than … CMV disease was 173 days, and CMV disease
was an independent predictor of mortality.Among patients with first episode retinitis, high CMV …

… for general use in the US. In addition to delaying the progression of CMV retinitis, cidofovir
may provide some protective benefits to patients at risk for developing the disease and may …

… systemic use of CDV in CMV disease … Cytomegalovirus infection was defined as a positive
CMV-specific assay in the absence of clinical symptoms, and CMV disease as a positive CMV …

… Cidofovir can be considered as second-line therapy in patients with CMV disease failing
previous … CDV has some attractive features for use in allogeneic SCT patients. Its therapeutic …

… cidofovir in patients with AIDS-related CMV retinitis. Anterior uveitis/iritis has been reported
frequently with intravenous cidofovir in … Other treatment options for CMV retinitis are also …

… As this study demonstrates, its use is associated with substantial renal and ocular toxicity
and suboptimal virologic outcomes. Less toxic and more effective antiviral options that target …

… , and cidofovir are antiviral drugs approved for use … CMV disease in other compromised
hosts (eg, pneumonitis in premature infants, CMV colitis in those with inflammatory bowel disease…

… dosing regimen for cidofovir in the treatment of CMV retinitis. Cidofovir is administered as an
… Isolates from patients enrolled in cidofovir CMV retinitis trials have been assayed for their …

… of his concurrent use of … that cidofovir may have prolonged in vivo antiCMV activity, although
this observation must be tempered by the fact that no patient demonstrated clearing of CMV …

… A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy:
use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 1989;…